Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Drazcanna Inc | 229.8K | 0.0x | --- |
Seelos Therapeutics Inc | 305.2K | 0.0x | --- |
Adynxx Inc | 580.0 | 0.0x | --- |
Aeolus Pharmaceuticals Inc | 150.0 | 0.0x | --- |
Regenerative Medical Technology Group Inc | 463.9K | 0.0x | --- |
DNAPrint Genomics Inc | 640.0 | 0.0x | --- |
DrazCanna, Inc. is engaged in providing cannabis products. The Company's products include flowers, edibles, extracts, topicals, and cannabidiol (CBD) products. The Company's extraction processes include CBD distillation for use in a line of topicals, edibles, oils and concentrates for consumer use. Its topical products provide opportunities for skin health and pain relief, such as anti-aging, skin disorder, pain relief and wound healing.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $229.8K |
---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 9.9M |
Drazcanna Inc does not pay a dividend. | |
Beta | 1.94 |
EPS | $-0.70 |
Book Value | $2.39 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -260.34% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.